← Back to headlines
Mpm Bioventures Sells $461,545 Stake in Entrada Therapeutics
Investment firm Mpm Bioventures has sold shares worth $461,545 in biotech company Entrada Therapeutics, according to recent filings.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
